Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
12/2003
12/25/2003US20030236409 Industrial process for preparing tropenol
12/24/2003WO2003106456A2 New compounds
12/24/2003WO2003106452A2 Antagonists of melanin concentrating hormone receptor
12/23/2003US6667314 Tropane derivatives useful in therapy
12/18/2003WO2003074500A3 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
12/18/2003US20030232993 Process for preparing scopine esters
12/18/2003US20030232827 Therapeutic compounds
12/18/2003US20030232819 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions
12/17/2003EP1278745B1 Sigma-2 receptors as biomarkers of tumor cell proliferation
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/16/2003US6664271 Immunopotentiator agents
12/11/2003WO2003101986A1 Technical method for producing tropenol
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/11/2003WO2002094273A3 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
12/11/2003US20030229227 New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
12/11/2003US20030229066 Central nervous system diosrders; psychological disorders
12/11/2003CA2725704A1 Industrial process for preparing tropenol
12/09/2003US6660863 Reacting an cycloheptatriene nitrile compound with nortropane compound
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/04/2003WO2003099783A2 Tropane compounds
12/04/2003US20030225100 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
12/04/2003US20030225060 Acylated piperidine derivatives as melanocortin-4 receptor agonists
12/04/2003CA2480742A1 Tropane compounds
12/03/2003EP1366018A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/02/2003US6656951 8-aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-HT1A antagonists
11/2003
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003WO2002072095A3 Tiotropium salts for treating inflammatory diseases
11/27/2003US20030220366 Nicotinamide derivatives useful as PDE4 inhibitors
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220316 Such as N-(1-(1-methylethyl)piperidin-4-yl)-N-((4-methyl phenyl)methyl)-4-methoxyphenylacetamide for stimulation of serotonin receptors
11/26/2003EP0765326B1 Benzoylecgonine, ecgonine and ecgonidine derivatives
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/20/2003WO2003094830A2 Novel azacyclic ethynyl derivatives
11/20/2003CA2480378A1 Novel azacyclic ethynyl derivatives
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361874A1 Treatment of diseases characterized by excessive or insufficient cell death
11/13/2003WO2003093249A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003WO2003057672A3 Tetrahydroquinoline analogues as muscarinic agonists
11/13/2003WO2001040188A8 Curcumin analogues for treating cancer
11/13/2003CA2484597A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/06/2003US20030207912 Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
11/05/2003EP1358177A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/05/2003EP1357905A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/05/2003CN1454087A The use of scopolamine salts
11/04/2003US6642246 Quinuclidine acrylamides
11/04/2003CA2123570C Cocaine receptor binding ligands
10/2003
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003031452A3 4-haloethenylphenyl tropane:serotonin transporter imaging agents
10/30/2003US20030204090 Administering to a patient an indazoline compound to treat cancer, inflammatory disorder or autoimmune disease
10/30/2003US20030203934 3-(substituted phenyl)-2-(substituted)tropane analogs which bind to cocaine receptors, dopamine transporter, serotonin transporter
10/30/2003US20030203928 Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/23/2003WO2003087097A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
10/23/2003WO2003087096A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
10/23/2003WO2003087049A2 Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent
10/23/2003WO2003086399A1 Medicaments containing steroids and a novel anticholinesterase drug
10/23/2003US20030199545 New esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
10/23/2003US20030199539 Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
10/23/2003US20030199529 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
10/21/2003CA2081344C Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003084502A1 Inhalation kit comprisung inhalable powder of tiotropium
10/16/2003WO2003039469A3 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1
10/16/2003US20030195233 Carbocyclic secondary amides such as 2-(4-fluoro-phenoxy) -N-(4-((2-hydroxy-3-methyl-benzoyl amino)-methyl)-benzyl)-nicotinamide, administered for prophylaxis of respiratory system disorders
10/15/2003EP1352906A1 Compositions for prevention or treatment of hepatopathy
10/14/2003US6632824 Have the ability to act at the 5-HT transporter.
10/14/2003US6632823 Substituted pyridine compounds useful as modulators of acetylcholine receptors
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082272A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191158 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/08/2003CN1447811A Medicinal compsns. and its use
10/02/2003WO2003080574A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003CA2479887A1 Piperidine or 8-aza-bicyclo¬3.2.1|oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
09/2003
09/25/2003WO2003078429A1 Micronized crystalline tiotropium bromide
09/25/2003WO2003078428A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/25/2003US20030181447 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
09/25/2003CA2476746A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/24/2003EP1345936A1 Method for producing the anticholinergic agent tiotropium bromide
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/23/2003US6624167 Compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and disorders associated with dysfunction of the central and autonomic nervous systems can
09/18/2003WO2003076398A2 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003US20030176418 For therapy of Alzheimer's disease, Parkinson's disease, schizophrenia, Huntington's chorea, Friederich's ataxia, Gilles de la Tourette's Syndrome, Down Syndrome, Pick disease, dementia, clinical depression, age- related cognitive decline
09/18/2003CA2477984A1 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/17/2003EP1343760A2 Muscarinic antagonists
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003US20030171586 Anticholinergic agents
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171347 Sigma receptor antagonist compounds that have anti-cocaine properties. These sigma receptor antagonists are useful in the treatment of cocaine overdose and addiction as well as movement disorders. The sigma receptor antagonists of the
09/10/2003CN1120841C Medicine composition and use thereof
09/09/2003US6617459 8-azabicyclo(3.2.1)oct-2-ene and 9-azabicyclo(3.3.1)non-2-ene derivatives; monoamine neurotransmitter and serotonine reuptake inhibitors; radionuclide-labeled derivatives for diagnosis and detection
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 53